REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-12-14

Reporting Person: SCHLEIFER LEONARD S (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-14	Non-Qualified Stock Option (right to buy)	$21.25	A	187500.0	Acquired	2019-12-18	Common Stock (187500.0)	Direct
2012-12-14	Non-Qualified Stock Option (right to buy)	$179.13	A	281250.0	Acquired	2022-12-14	Common Stock (281250.0)	Direct

Footnotes

F1: On December 18, 2009, the reporting person was granted an option to purchase 187,500 shares of Common Stock. The option vests, partially or in full, on December 31, 2012, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2012. The performance criteria have been met and the option will vest as to all 187,500 shares on December 31, 2012.

F2: Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.

F3: The stock option award vests in four equal annual installments, commencing one year after the date of grant.